Back to ISAPS Newsroom

Statements & Guidelines

As the leading society in aesthetic plastic surgery, ISAPS publish Safety Guidelines based on the latest evidence-based information to contribute to patient's safety worldwide.

Filter

Date
Topic
Published Date (Desc)
Statements & Guidelines

Recommendations on how to reduce blood loss in plastic surgery and blood transfusions

Date
Mar 18 2024
Statements & Guidelines

Breast Implant Removal and Capsulectomy

Date
May 09 2023
Statements & Guidelines

Patient Safety Advisory– Fentanyl

Date
Feb 02 2023
Statements & Guidelines

Illegal Use of Injectable Silicone for Body Contouring and Associated Health Risks

Date
Feb 01 2023
Statements & Guidelines

ISAPS Endorsed Patient Safety Statement: Gluteal Fat Grafting

Date
Nov 03 2022
Statements & Guidelines

US FDA Safety Communication on Breast Implant Associated Squamous Cell Carcinoma (BIA-SCC)

Date
Oct 18 2022
Statements & Guidelines

ASPS/ASAPS Update Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)

Date
Nov 09 2019
Statements & Guidelines

Information for Breast Implant Patients

Date
Nov 09 2019
Statements & Guidelines

BIA-ALCL Safety Advisory

Date
Aug 01 2018
Statements & Guidelines

Prevention of Surgical Fires

Date
Jun 01 2017
Statements & Guidelines

Body Dysmorphic Disorder

Date
May 20 2017
Join ISAPS

ISAPS

19 Mantua Road, Mount Royal, NJ 08061 United States

Registration number: 0330131

US Office: +1-603-643-2325

UK Office: +44 20 7038 7812

© 2022 International Society of Aesthetic Plastic Surgery. All Rights Reserved.